NEW YORK (GenomeWeb) – NanoString Technologies said after the close of the market on Monday that its preliminary second quarter revenues grew about 11 percent year over year, exceeding previous guidance.

The company also announced a $50 million underwritten public offering of its common stock, pursuant to an existing shelf registration statement. In connection with the offering, NanoString said it also expects to grant underwriters a 30-day option to purchase up to $7.5 million worth of additional common shares.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.